Boston Scientific Corporation vs CSX Corporation — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while CSX Corporation trades at $50.03 (market cap $92.55B). The key difference: CSX Corporation is the larger of the two by market cap, and CSX Corporation pays a 1.12% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | CSX | |
|---|---|---|
Market Cap | $74.19B | $92.55B |
Sector | Health | Industrials |
52-Week High | $108.14 | $53.21 |
52-Week Low | $42.63 | $32.05 |
Enterprise Value | $86.27B | $110.52B |
Dividend Yield | — | 1.12% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →